Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2,120.00p 2,070.00p 2,170.00p 2,120.00p 2,120.00p 2,120.00p 252 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 7.2 5.8 96.4 22.0 108.09

Bioventix Share Discussion Threads

Showing 751 to 775 of 775 messages
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
DateSubjectAuthorDiscuss
23/2/2018
14:11
AFAIK, there is nothing new about using CT scanning to detect heart disease as this link shows hTTps://www.bhf.org.uk/heart-matters-magazine/medical/imaging-techniques/ct-scans I know something of this because a family member is routinely scanned for disease. However, it sounds as if there is a new machine that can do it much faster as reported here in the USA hTTp://www.wndu.com/content/news/Texas-hospital-offers-new-treatment-to-detect-heart-disease-393306011.html How the Ulster scanner claims to be the worlds first isn't clear.
alter ego
23/2/2018
13:43
FWIW, World’s First CT Scanner For Heart Disease Installed At Ulster Hospital https://tinyurl.com/yad2ncrx
piedro
14/2/2018
15:01
Would be very nice to get back to the 2100-2200p range shortly. Today's late move looks encouraging.
lauders
13/2/2018
14:20
gsbmba99, Thank you for your update. The biggest problem seems to be whether what these tests detect is an authentic indication of the onset of alzheimers
piedro
13/2/2018
12:10
This is a great company that I have often tried to invest in only to find the spread has put me off, much to my loss! It's now at a reasonable entry price but I still have a concern. Sensors such as nano sensors that can measure extremely small particles in our breath are being developed to diagnose many different diseases, yes they are still in early stage developement but when they become commercialised I think the whole medical diagnosis industry will be disrupted including Bioventix. It's just a matter of time. Is BVXP currently a good investment? I don't know at this price to be honest. (Not a holder, just wondered what others views are)
pi0110
13/2/2018
11:18
Piedro - there are multiple blood tests for beta-amyloid in development. Adx Neurosciences say they have a blood test for beta-amyloid ( Http://www.adxneurosciences.com/en/pipeline ). The pipeline slide suggests that this test is already in Research use Only (RuO) or, possibly, even further advanced. They, I believe, are partnered with Euroimmun (now part of Parker Hannifin). Bateman et al are working on a blood test for the ratio of beta-amyloid 1-42 to 1-40 ( Https://medicine.wustl.edu/news/blood-test-ids-key-alzheimers-marker-brain/ ). There's a potential blood test using diamonds ( Https://www.eurekalert.org/pub_releases/2017-09/lu-bsr090617.php ). There are also competing technologies such as a retinal scan ( Https://alzheimersnewstoday.com/2017/08/21/alzheimers-experts-say-new-eye-scan-that-detects-protein-in-retina-could-aid-in-quicker-diagnoses/ ). It's hard to discern how advanced the various tests are and whether they are suitable for the high-throughput blood test machines BVXP ordinarily supplies.
gsbmba99
12/2/2018
16:07
competition ?? .. 31 JANUARY 2018 Simple blood test spots dementia protein Scientists hope to use the cheap-and-easy test to help develop better treatments for Alzheimer’s disease. https://www.nature.com/articles/d41586-018-01466-8
piedro
12/2/2018
11:14
I bought an initial stake too but a bit too soon so hoping the fall has been arrested.
alter ego
12/2/2018
09:17
Topped up here last week (Friday) so hoping it was a sensible thing to do. So far looks promising.
lauders
02/2/2018
15:48
LSE call what everyone else calls ordinary trades "off book" because they are not traded via the SETS order book (and never have been even when LSE called them 'ordinary'). Blame Mifid II.
sharw
02/2/2018
12:24
LSE website
tadders2
02/2/2018
12:12
where do you get the info for off book trades? I can only see "O" ordinary trades going through.
tiswas
02/2/2018
11:16
Anybody got any idea what’s going on with all these off book trades?
tadders2
01/2/2018
11:21
Pre-diagnostics and Cardinor are presenting at Swiss Nordic Bio 2018 next week ( Http://swissnordicbio.com/index.php/swiss-nordic-bio-agenda ). Can't see any new info on either company when I click through to their speaker bios. Inven2 is reporting ( Https://translate.googleusercontent.com/translate_c?depth=1&hl=en&ie=UTF8&prev=_t&rurl=translate.google.com&sl=auto&sp=nmt4&tl=en&u=Https://www.inven2.com/en/news/201801/cardinor-ranket-som-nr-36-av-462-av-eurostars&usg=ALkJrhgxRK_XLO1MSnpwtgrnJXSTjquHCg ) that Cardinor was part of a consortium receiving NOK11m (c. GBP1m) of funding from the Eurostars program for development and initial production of the biomarker (presumably secretoneurin).
gsbmba99
15/12/2017
12:34
That'll be "half year" ending in December.
crazycoops
15/12/2017
11:48
I went to the AGM last year and there were about 5 shareholders. What a difference a year makes.
gsbmba99
15/12/2017
08:09
There were about 50 people in attendance. Pricing pressures were mentioned, with no indication released how the current year is doing which is ending at 31 December. There was no profit warning, though chairman reconfirmed that returns to shareholders will continue in the form of dividends and special dividends. The company was happy to confirm that very acceptable new shareholders joined during the year.
a1samu
14/12/2017
07:21
Anybody going to the AGM?
tadders2
12/12/2017
09:08
Also some recent research on beta-amyloid which included Tormod Fladby as a contributor in the Psychiatry journal of the American Medical Association. Https://www.ncbi.nlm.nih.gov/pubmed/29188296 Results: "In persons with normal cognition, the age-related increase in low memory score paralleled the age-related increase in amyloid positivity with an intervening period of 10 to 15 years." Not entirely sure how to interpret the results but seems generally supportive of the theory that beta-amyloid increases pre-date cognitive decline by 10+ years.
gsbmba99
12/12/2017
08:53
Some recent research by the wider team in Norway published on Secretoneurin in the November issue of Circulation, a journal of the American Heart Association. Http://circ.ahajournals.org/content/136/Suppl_1/A14626 and Http://circ.ahajournals.org/content/136/Suppl_1/A13900 . The first conclusion says: "SN [secretoneurin] levels provide prognostic information in patients with ACS [acute coronary syndrome], but not in patients hospitalized with non-cardiac chest pain." The second conclusion says: "Production of SN [secretoneurin] may be an endogenous protective mechanism in patients with pathological cardiomyocyte Ca2+ handling, supporting its role as an emerging biomarker."
gsbmba99
08/12/2017
20:47
Not going but would be grateful to hear from anyone who is.
tadders2
08/12/2017
20:19
Anyone going to the AGM? The share price seems to be reflecting the lack of news for a wee while now and has been on a downward trend of late. (guess whose stop loss kicked in today)
soundsplausible
06/12/2017
06:42
Https://www.prnewswire.com/news-releases/roche-supports-fda-communication-about-potential-for-biotin-interference-with-lab-tests-300565232.html Roche has issued guidance on the interaction of Biotin (Vit B7) and streptavidin based assays (including hs-troponin). Dosages of 1mg (as contained in general multi-vitamins) pose no risk of test result interference. With dosages of >5mg, 8hr wait time between taking Biotin and blood draw is recommended. I think this is the study ( Https://www.future-science.com/doi/10.4155/ipk-2017-0013 ) which was conducted in Sep-Oct 16 and recently published. I wonder if the FDA had pre-warned manufacturers they were going to have to study this issue last year?
gsbmba99
06/12/2017
06:31
Http://www.captodayonline.com/next-gen-troponin-gate-labs/ Useful article discussing process for introducing the Roche hs-troponin test at a selection of US hospitals. Early returns, as described in article, appear to be pretty good.
gsbmba99
04/12/2017
09:51
Bioventix isn't presenting in Oslo. It's only Pre-Diagnostics and CardiNor.
gsbmba99
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180223 14:59:09